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Reproducibility of Transcranial Doppler
ultrasound in the middle cerebral artery
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and David E. Newby1
Abstract
Background: Transcranial Doppler ultrasound remains the only imaging modality that is capable of real-time
measurements of blood flow velocity and microembolic signals in the cerebral circulation. We here assessed the
repeatability and reproducibility of transcranial Doppler ultrasound in healthy volunteers and patients with
symptomatic carotid artery stenosis.
Methods: Between March and August 2017, we recruited 20 healthy volunteers and 20 patients with symptomatic
carotid artery stenosis. In a quiet temperature-controlled room, two 1-h transcranial Doppler measurements of
blood flow velocities and microembolic signals were performed sequentially on the same day (within-day
repeatability) and a third 7–14 days later (between-day reproducibility). Levels of agreement were assessed by
interclass correlation co-efficient.
Results: In healthy volunteers (31±9 years, 11 male), within-day repeatability of Doppler measurements were 0.880
(95% CI 0.726–0.950) for peak velocity, 0.867 (95% CI 0.700–0.945) for mean velocity, and 0.887 (95% CI 0.741–0.953) for
end-diastolic velocity. Between-day reproducibility was similar but lower: 0.777 (95% CI 0.526–0.905), 0.795 (95% CI 0.
558–0.913), and 0.674 (95% CI 0.349–0.856) respectively. In patients (72±11 years, 11 male), within-day repeatability of
Doppler measurements were higher: 0.926 (95% CI 0.826–0.970) for peak velocity, 0.922 (95% CI 0.817–0.968) for mean
velocity, and 0.868 (95% CI 0.701–0.945) for end-diastolic velocity. Similarly, between-day reproducibility revealed lower
values: 0.800 (95% CI 0.567–0.915), 0.786 (95% CI 0.542–0.909), and 0.778 (95% CI 0.527–0.905) respectively. In both
cohorts, the intra-observer Bland Altman analysis demonstrated acceptable mean measurement differences and limits
of agreement between series of middle cerebral artery velocity measurements with very few outliers. In patients, the
carotid stenoses were 30–40% (n = 9), 40–50% (n = 6), 50–70% (n = 3) and > 70% (n = 2).
No spontaneous embolisation was detected in either of the groups.
Conclusions: Transcranial Doppler generates reproducible data regarding the middle cerebral artery velocities.
However, larger studies are needed to validate its clinical applicability.
Trial registration: ClinicalTrial.gov (ID NCT 03050567), retrospectively registered on 15/05/2017.
Keywords: Transcranial Doppler, Microembolic signals, Carotid artery stenosis, Ischaemic stroke
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Background
Ischaemic stroke remains a major global cause of disabil-
ity and death that is associated with an enormous social
and economic burden [1]. Up to 25% of ischaemic
strokes are caused by atherosclerosis of the internal ca-
rotid artery [2, 3]. Carotid atherosclerosis is a complex
disease that is characterised by the deposition of luminal
atheroma that may rupture, thrombose and embolise [2].
The resulting thromboembolism can lead to a stroke or
transient ischaemic attack (TIA) [4].
Transcranial Doppler is a well established real-time
imaging modality that evaluates cerebral blood flow vel-
ocity and detects microembolic signals in patients who
suffer from cerebral or retinal ischaemia [5]. Microem-
bolic signals in symptomatic carotid artery stenosis are
associated with an increased risk of a recurrent ipsilat-
eral focal ischaemia [6–14] and and correlate with a
greater number of magnetic resonance imaging detect-
able cerebral infarcts when compared with patients free
from microembolism [15–18]. The intraoperative trans-
cranial Doppler has enabled clinicians to lower the rate
of the most serious post carotid endarterectomy com-
plication such as thromboembolic stroke from 4 to
0.2% through detection of the middle cerebral artery
flow cessation due to the intraluminal carotid artery
thrombosis [19, 20]. Whereas, transcranial Doppler
directed infusion of Dextran 40 has in some centres
successfully erased the rate of postoperative thro-
mboembolic cerebral ischaemia from 2.7 to 0% [8, 21].
Despite these benefits from transcranial Doppler,
routine use has not been advocated amongst vascular
specialists.
Although multiple studies have been conducted on
flow velocities in basal cerebral arteries in both healthy
volunteers and patients [22–33], reproducibility data are
limited to a hand full of reports. These include four arti-
cles involving healthy subjects [34–37] and one study
that recruited patients with clinical diagnosis of ischae-
mic stroke (n = 3) or TIA (n = 7) but provided no infor-
mation regarding the clinical type of neurovascular
event or underlying carotid artery stenosis [5]. In con-
trast, published data on microembolic signals detection
in patients with symptomatic carotid artery stenosis in-
cludes systematic reviews, meta-analyses [38–41] inter-
national multicenter reproducibility studies that have
described the reproducibility of transcranial Doppler as
sufficient for clinical use [10, 42, 43].
Our objective was to assess the intra-observer repeat-
ability and reproducibility of transcranial Doppler for
velocimetry measurements and microemboli detection
in healthy volunteers and patients with symptomatic ca-
rotid artery stenosis that could form the basis for our fu-
ture study investigating reliable identification of a
vulnerable carotid plaque.
Methods
Study design
This was an observational investigative study. The
study was approved by the local Research Ethics Com-
mittee (16/SS/0217), and written consent was obtained
from all participants. The research protocol is available
on ClinicalTrial.gov (ID NCT 03050567).
Study population
Cohorts (n = 20 per cohort) of healthy volunteers and
patients with symptomatic carotid artery stenosis were
recruited between March–August 2017. Among the pa-
tient group, five patients that were excluded due to an
absent temporal window, were subsequently replaced.
Healthy volunteers were > 18 years old and had no previ-
ous history of cerebrovascular disease. Patients with evi-
dence of an acute neurovascular syndrome (stroke, TIA,
retinal ischaemia) due to carotid artery disease were re-
cruited from the acute neurovascular clinics at Edin-
burgh Royal Infirmary within a maximum of 14 days of
symptom onset. The inclusion criteria were the symp-
tomatic cerebrovascular event (stroke, TIA or amaurosis
fugax) and radiological confirmation of carotid artery
stenosis of > 30%. This included patients scheduled for
carotid endarterectomy (> 50% for men and > 70% for
women, by North American Symptomatic Carotid End-
arterectomy Trial criteria) or treated conservatively with
an optimal medical therapy (if patient declined surgical
intervention or is outside surgical criteria for carotid
endarterectomy) [3].
Study protocol
All subjects underwent clinical evaluation prior to par-
ticipation. In the patient group, this included assessment
of relevant carotid Doppler ultrasound and brain im-
aging investigations (computed tomography or magnetic
resonance imaging). In both cohorts, three 1-h transcra-
nial Doppler measurements were performed by the same
examiner over two study visits. During the first study
visit, two examinations were performed separated by 1 h
(Fig. 1). The final (third) examination was obtained on a
separate study visit within 14 days of the first examin-
ation (Fig. 1).
Transcranial Doppler ultrasound
All examinations were performed in a semi-recumbent
position in a quiet temperature-controlled room. The
middle cerebral artery was identified through the tem-
poral window and the sample volume adjusted to obtain
a stable visually and acoustically optimal signal. In
healthy subjects, the side of the middle cerebral artery
insonation was randomly allocated. In patients with
symptomatic carotid artery stenosis, transcranial Dop-
pler was performed on the symptomatic middle cerebral
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artery (ipsilateral to the index event). A head frame
(Marc 600 Spencer Technologies, USA) was fitted to re-
duce motion and to secure a constant angle of the mid-
dle cerebral artery insonation depth at 40–65 mm from
the skull surface. All recordings were made using the
ST3 Transcranial Doppler Ultrasound System (Spencer
Technologies, USA) with a 2-MHz transducer. Emboli
were identified using characteristic short audible sound
(range 10–100 ms, intensity threshold above 7 dB) and
spectral appearance using the International Consensus
Group microembolus identification criteria and assisted
by an automated Embolus Detection Software (Spencer
Technologies, USA) [44]. The Doppler wave forms were
reassessed to exclude artefact and confirm the presence
of true emboli. The mean of maximal, mean and
end-diastolic flow velocities were determined from the
mean of measurements obtained over ten cardiac cycles.
Statistical analysis
Continuous variables were expressed as mean ± standard
deviation for normally distributed data, and categorical
variables were expressed as total and percentage. To
quantify intra-observer repeatability and reproducibility
of imaging measurements, the intra-class correlation
co-efficient (ICC) was calculated and Bland-Altman ana-
lysis undertaken. Statistical significance was taken as a
two-sided P < 0.05. Statistical analyses were performed
with the use of IBM SPSS Statistics for Mac, version 23
(Armonk, New York, IBM Corp, USA).
Results
All participants tolerated transcranial Doppler examina-
tions well and completed all assessments.
Healthy volunteers
In total, 60 transcranial Doppler assessments were per-
formed on 20 healthy volunteers who had a mean age of
31±9 years, and 11 were male. All subjects had the tem-
poral window available, and the mean middle cerebral
artery insonation depth was 51 mm (Table 1) with peak
velocities averaging around 70–85 cm/s (Table 1).
Overall, the ICC for both repeatability and reproduci-
bility in healthy volunteers group revealed a good reli-
ability (ICC 0.75–0.90) with wider confidence intervals
obtained for the peak and mean reproducibility values
when compared with the repeatability measurements
(Table 2). An intra-observer Bland Altman analysis
demonstrated acceptable mean measurement differ-
ences and limits of agreement between series of middle
cerebral artery velocity measurements with very few
outliers (Figs. 2 and 3). As expected no microembolic
signals were detected.
Patients
Patients had a mean age of 72±11 years, and 11 were men
(Table 3). Presenting diagnosis included 18 transient
ischaemic attacks (11 cerebral, 7 ocular) and 2 cases of is-
chaemic stroke. The degree of stenoses measured by
Duplex ultrasound scan were: 30–40% (n = 9), 40–50%
(n = 6), 50–70% (n = 3) and > 70% (n = 2). Five patients
(4 females, 1 male) had an absent acoustic temporal
window. The mean middle cerebral artery insonation
depth was 51 mm (Table 1) and peak cerebral artery
Table 1 Summary of the middle cerebral artery blood flow
velocity and insonation depth in healthy volunteers and
patients
Healthy Volunteers
Velocity (cm/s) Examination 1 Examination 2 Examination 3
Peak 75.70 ± 23.91 72.00 ± 20.28 82.75 ± 19.93
Mean 49.95 ± 15.30 47.05 ± 12.85 52.60 ± 11.73
Diastolic 34.70 ± 11.28 29.50 ± 10.65 35.45 ± 8.40
MCA depth (mm) 51.75 ± 2.65 51.75 ± 2.94 51.20 ± 2.93
Patients
Velocity (cm/s) Examination 1 Examination 2 Examination 3
Peak 73.70 ± 18.94 73.10 ± 16.62 71.20 ± 17.62
Mean 45.40 ± 11.79 45.20 ± 10.83 43.50 ± 9.96
Diastolic 27.30 ± 8.90 27.10 ± 8.14 25.60 ± 6.57
MCA depth (mm) 51.40 ± 5.33 51.55 ± 5.21 51.65 ± 5.24
Data are presented as mean ± standard deviation. MCA, middle cerebral artery
Table 2 Summary of ICC velocity values for repeatability and
reproducibility assessments in healthy volunteers and patients
Healthy Volunteers
Repeatability (Exam 1 vs Exam 2) ICC 95% CI
Peak 0.880 0.726–0.950
Mean 0.867 0.700–0.945
End-diastolic 0.887 0.741–0.953
Reproducibility (Visit 1 vs Visit 2) ICC 95% CI
Peak 0.777 0.526–0.905
Mean 0.795 0.558–0.913
End-diastolic 0.674 0.349–0.856
Patients
Repeatability (Exam 1 vs Exam 2) ICC 95% CI
Peak 0.926 0.826–0.970
Mean 0.922 0.817–0.968
End-diastolic 0.868 0.701–0.945
Reproducibility (Visit 1 vs Visit 2) ICC 95% CI
Peak 0.800 0.567–0.915
Mean 0.786 0.542–0.909
End-diastolic 0.778 0.527–0.905
Date are reported as mean with 95% limits of agreement for assessments
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blood flow velocities were 70–75 cm/s (Table 1). The
overall intra-observer ICC for repeatability and repro-
ducibility displayed at least good (ICC 0.75–0.90) agree-
ment that reached an excellent agreement (ICC > 0.90)
for the peak and mean repeatability velocity values
(Table 2). Similarly, wider confidence intervals were
found for the peak and mean reproducibility values
when compared with the repeatability assessments. The
Bland Altman plots showed acceptable mean measure-
ment differences and limits of agreement between
series of middle cerebral artery velocity measurements
with very few outliers (Figs. 4 and 5). No microembolic
signals were detected during transcranial Doppler
assessments.
Discussion
In this study, we have demonstrated that transcranial
Doppler generates reproducible data regarding the vel-
ocity measurements. Transcranial Doppler utilises an
acoustic temporal bone window through which the
ultrasound beam can focus on the middle cerebral ar-
tery, which receives 80% of an ipsilateral internal carotid
artery inflow [27]. The obtained middle cerebral artery
insonation depth in both cohorts reflects published data
[10, 45, 46].
In general, the success of transcranial Doppler imaging
diminishes with an older age due to an increased tem-
poral bone thickness that impairs the transmission of
ultrasound waves through the skull [47, 48]. This has
been observed primarily in approximately 10% of
non-Caucasian elderly female participants [49]. However,
others report temporal window failure in almost third of
examined subjects [50].
Multiple studies described substantially different nor-
mal reference velocity values of cerebral arteries blood
flow [22, 24, 25, 27, 29, 31] but the most frequently
quoted normal middle cerebral artery velocity under
resting condition ranges from 35 to 90 cm/sec with a
mean of 60 cm/sec [29]. Our velocity values mirror the
results published by others, except for the lower mean
Fig. 1 Three transcranial Doppler examinations of the same participant (visit 1: images a and b; visit 2: image c)
a b c
Fig. 2 Repeatability in healthy volunteers (Examination 1 vs Examination 2): Bland Altman analysis for middle cerebral artery velocity. a) Peak. b)
Mean. c) End-diastolic
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diastolic middle cerebral artery velocity. However, this
could be explained by various physiological and tech-
nical factors that can affect velocity readings. First,
physiological cardiovascular changes such as heart rate,
blood pressure, respiratory rate, arterial carbon dioxide
tension alter middle cerebral artery blood flow on a daily
basis [51, 52]. Second, psychological factors (emotional
state, fatigue) by influencing the above physiological car-
diovascular autonomic responses can impact on the
cerebral blood flow [51]. Unsurprisingly, changes in the
cerebral metabolism due to cognitive activation also
affect the middle cerebral artery blood flow. Some au-
thors demonstrated that arithmetic activity produced
very similar values to the resting blood flow values,
whereas higher levels of arithmetic difficulty produced
smaller changes in the blood flow [53]. Therefore, the
above factors could have potentially influenced the ob-
tained velocity values.
The main technical aspect that can impact on velocity
measurement is the angle of insonation that is obtained
between the middle cerebral artery and ultrasound beam
[5, 34]. However, this is more relevant when large acous-
tic window such as the foramen of magnum is used, be-
cause it permits significant angle variation [34].
Fortunately, small temporal window with a sharp angle
of insonation (0°-30°) that is relatively stable minimises
any influence on obtained velocities values [5]. Hence,
the maximum error has been estimated to be less than
15% [34, 35]. Finally, individual variability of the middle
cerebral artery size, length and tortuosity are also con-
tributing to the scattering of the velocity measurements
[27, 29, 37].
In general, cerebral flow velocity decreases with age in
a bimodal pattern with a first decline above the age of
40 years and a further reduction above 60 years of age
[22, 26, 27, 54]. Unsurprisingly, our data demonstrate
similar results with lower velocity values in patients co-
hort when compared with the healthy volunteers. Over-
all the obtained ICC values in our study represent a
good repeatability and reproducibility in both cohorts.
However, the peak and mean ICC repeatability values re-
corded in patients group reached an excellent agreement
(ICC > 0.90). In both cohorts, the peak and mean ICC
reproducibility values decrease with wider confidence in-
tervals when compared to the repeatability values. This
likely reflects the combination of technical variation and
biological variation which will be much greater when
measurements are conducted on separate days rather
than within a day. For example, this could include probe
displacement from the original middle cerebral artery
segment that was sampled during the first study visit.
This may also reflect the well described anatomical vari-
ability of the circle of Willis including diameter discrep-
ancy of the individual parts of the middle cerebral artery
[27, 29]. In effect, an over or under-estimated velocity
values can be reported depending on the diameter of an
insonated artery. The slightly higher ICC values obtained
in the patients group could be explained by the lower
Table 3 Baseline characteristics of patients
Characteristics n (%)
Total = 20
Demographics
Age, years 72±10.6
Male 11 (55)
Vital signs
Systolic BP 146.6
±27.3
Diastolic BP 77.4±11.0
Heart rate/min 70.15
±14.89
Smoker status
Current smoker 2 (10)
Former smoker 12 (60)
Never smoked 6 (30)
Presenting diagnosis
Cerebral TIA 9 (45)
Ocular TIA 7 (35)
Stroke 2 (10)
Duplex scan severity of stenosis (%)
30–40% 9 (45)
4–50% 6 (30)
50–70% 3 (15)
> 70% 2 (10)
Duration between index event and 1st transcranial
Doppler (days)
11.6±2.4
Relevant medical history
Hypertension 15 (75)
Hypercholesterolemia 20 (100)
Diabetes Mellitus 3 (15)
Ischaemic Heart Disease 4 (20)
Peripheral Vascular Disease 1 (5)
TIA 4 (20)
Stroke 3 (15)
Chronic Obstructive Pulmonary Disease 3 (15)
Baseline medication therapy
Antiplatelet 18 (90)
Anticoagulant 2 (10)
Statin 20 (100)
Beta-blocker 4 (20)
Angiotensin-converting enzyme inhibitor 7 (35)
Data are presented as mean (standard deviation) or as percentage (%)
where appropriate
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range of physiological fluctuations and more consistent
velocity measurements [28].
Finally, the equipment characterists such as head frame
that supports the transducers could account for some dif-
fernces in velocity values. In our study we have used a pro-
fessional head frame system (Marc 600 Spencer
Technologies, USA) that minimises the motion and main-
tains a constant angle of insonation of the middle cerebral
artery. Interestingly, no single reproducibility study on vel-
ocity measurements described any form of secure fixation
of transducers during the examinations [5, 34–37]. Simi-
larly, systematic reviews and meta-analyses on microem-
bolic signals detection provide no information on any
head-frame systems used by individual studies [38–41].
This raises many questions regarding the methodological
aspects of these studies that have been conducted more
than 20 years ago.
Although our data regarding transcranial Doppler vel-
ocities measurements echoes other researchers findings,
it should be interpreted with caution owing to many
methodological limitations of the published analyses
including a limited number of reproducibility studies
that contain small sample size and variable imaging pro-
tocols. Furthermore, evidence for the transcranial Dop-
pler criteria to predict the degree of intracranial arteries
stenoses remains inconclusive and controversial [18].
Several studies failed to demonstrate reproducible data
on specific cut-off points for the velocities values with
the percentage of stenosis [30, 32, 33, 55–57]. Some
authors have proposed middle cerebral artery velocity of
> 80 cm/sec as a criterion for stenosis [57], whereas
others used velocities > 100 cm/sec when diagnosing
stenosing lesions [54]. In contrast, some researchers have
highlighted the importance of additional measurements
such as side-to-side differences in velocities (> 30%) or in-
crease in velocity (> 50%) along with the assessment of
collateral flow using temporary manual occlusions of the
common carotid artery [30, 32]. However, one must re-
member potential pitfalls with such approach because
high velocities in collateral circulation can indicate differ-
ent diameters of the middle cerebral arteries on two sides
[30]. In effect, high blood flow velocities may be caused
simply by the smaller diameter of MCA despite otherwise
normal anatomy [33]. Finally, the largest study (The
a b c
Fig. 3 Reproducibility in healthy volunteers (visit 1 vs Visit 2): Bland Altman analysis for middle cerebral artery velocity. a) Peak. b) Mean.
c) End-diastolic
a b c
Fig. 4 Repeatability in patients (Examination 1 vs Examination 2): Bland Altman analysis for middle cerebral artery velocity. a) Peak. b) Mean. c)
End-diastolic
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Stroke Outcomes and Neuroimaging of Intracranial Ath-
erosclerosis (SONIA) Trial) that attempted to validate
transcranial Doppler findings with magnetic resonance
angiography against the standard cerebral digital subtrac-
tion angiography regarding the identification of intracra-
nial arterial disease revealed disappointingly low results of
positive predictive values for transcranial Doppler (36%)
and magnetic resonance angiography (59%) [55]. In effect,
the transcranial Doppler’s clinical applicability regarding
the abnormal velocity values assessment remains limited.
Despite complete 1-h transcranial Doppler assess-
ments performed in our study, the lack of microembolic
signals in patients with symptomatic carotid artery
stenosis was disappointing. The reported incidence var-
ied from 12 to 100% in individual studies [40, 58, 59].
Nevertheless, considerable differences regarding criteria
for microembolic signals detection, timing after stroke,
duration of monitoring and antithrombotic agents used
have been identified among many studies [10, 40, 58].
Consequently, the majority of published data described
microembolic signals in about 30–40% of individuals
with symptomatic carotid artery stenosis when transcra-
nial Doppler was performed for 1 h [39, 40, 59, 60].
Still, there are several potential explanations for the
absent embolisation. Thromboembolism is a dynamic
and random process with a generally reported low fre-
quency of microembolic signals during 1-h long examin-
ation [60, 61]. Although 1-h long transcranial Doppler
evaluation time is recommended for patients with symp-
tomatic carotid artery stenosis, longer assessments in-
crease the chances of successful emboli detection [60].
This was demonstrated by ambulatory recordings
(greater than 5 h) with portable transcranial Doppler
equipment that has yield greater number of microem-
bolic signals when compared with the traditional 60 min
approach [62, 63]. However, at present, an ambulatory
transcranial Doppler recording remains primarily a re-
search tool due to lack of a robust equipment.
Another possible explanation refers to the severity of
carotid artery stenosis and plaque morphology. Micro-
embolic signals are more common in patients with the
higher degree of carotid artery stenosis, which in turn is
associated with specific carotid plaque features reported
histologically such as ulceration, intraplaque haemor-
rhage and surface thrombus [11, 18, 39, 49, 59, 64, 65].
These high-risk plaque features are more likely to lead
to the development of stroke because they produce lar-
ger emboli that consist of thrombi [59]. Whereas, small
embolic particles comprising of fibrin and platelets ag-
gregates that lodge in small arteriolar branches, may be
lysed by endogenous protective haemostatic defences,
hence clinically may represent TIA [59]. The majority of
our patients had a non-surgical grade of carotid artery
stenosis and presented with TIA. Therefore, these factors
could be potentially responsible for no detectable micro-
embolic signals.
The various components of microembolic signals re-
sponds differently to treatment [39]. For example, anti-
platelet agents are more effective for emboli originating
from the symptomatic carotid artery stenosis, and re-
duce the rate of microembolic signals [11, 12]. On the
other hand, anticoagulants deal more effectively with
microembolic signals from a cardiac source [11, 39]. The
majority of participants (90%) in our study have been on
an antiplatelet agent at the time of the first transcranial
Doppler assessment, and this could represent another
potential confounder. Finally, microembolic signals are
more likely to be detected within the first week after the
index event, and in patients with recent stroke rather
than with TIA [66]. Again, we have performed transcra-
nial Doppler as soon as possible, but due to various lo-
gistic factors, only two patients had transcranial Doppler
within seven days from their index event.
The main limitations of this study are the small sample
size, and single-centre design. However, the main pur-
pose of the study was to demonstrate reproducibility of
a b c
Fig. 5 Reproducibility in patients (visit 1 vs Visit 2): Bland Altman analysis for middle cerebral artery velocity. a) Peak. b) Mean. c) End-diastolic
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the transcranial Doppler and this was achieved. At
present, transcranial Doppler remains underutilised in
clinical practice due to lack of human expertise,
time-consuming recordings with the need for a continu-
ous visual and audible evaluation [13, 60]. Furthermore,
unsolved technical and methodological limitations of
transcranial Doppler regarding the velocity assessments
restrict its clinical applicability. However, its use during
carotid surgery has shown that the clinical use of this
non-invasive, non-ionising, portable and safe technique
could be extended to vascular surgery specialists as part
of the routine perioperative strategy that could reduce
the risk of neurovascular events even further [20].
Conclusions
Our findings indicate that transcranial Doppler provides
reproducible data on middle cerebral artery velocities.
However, these findings should be interpreted with cau-
tion for the many technical and methodological limita-
tions that the transcranial Doppler still presents. Larger
studies with the colour transcranial Doppler may enable
delivery of a robust data on velocity assessments along
with the quantification of intracranial stenoses.
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